Drug Development
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien
Published in Lab Business Week, May 13th, 2007
Zolpidem Tartrate is a sedative-hypnotic drug, which is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. This new product is the bioequivalent to Ambien(R), a registered trademark of Sanofi-aventis. Ambien(R) had U.S. sales of approximately $2.09 billion for the 12-month period ended Dec. 31, 2006, according to IMS Data. Caraco has two strengths available, 5 mg and 10 mg tablets.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-05-13)
More Articles from Lab Business Week
- Axon Labs, Inc.
Axon Labs Names David P. Dickinson as Chief Executive Officer - Bird Flu
Carrington Subsidiary Delsite Biotechnologies Secures Antigen for Phase I Clinical Trial of Nasal Powder Influenza Vaccine - Clostridium
Reports summarize clostridium study results from Kyoto Biken Laboratories, Inc. - Dermatology
Stiefel Laboratories Moves to Solidify, Enhance Its Leadership Position in Dermatology - Drug Development
Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets - Drug Development
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
